Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Goethe University Frankfurt, University Hospital, Department of Urology, Frankfurt am Main, Germany.
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Surg Oncol. 2024 Apr;53:102047. doi: 10.1016/j.suronc.2024.102047. Epub 2024 Feb 13.
It is unknown whether the benefit from partial nephrectomy regarding lower other-cause mortality is applicable to older patients with metastatic renal cell carcinoma.
Using Surveillance Epidemiology and End Results database, patients with metastatic renal cell carcinoma, undergoing partial or radical nephrectomy, were stratified according to age (<60, 60-69, and ≥70 years). After propensity score matching, Kaplan-Meier survival analyses and multivariable Cox regression models were used.
Of 2,390 patients with metastatic renal cell carcinoma, 885 (37%) were aged <60 years, and 90 (10%) underwent partial nephrectomy; 824 (34%) were aged 60-69 years, and 61 (7%) underwent partial nephrectomy; and 681 (29%) were aged ≥70 years, and 64 (9%) underwent partial nephrectomy. After propensity score matching, in patients aged <60 years, partial nephrectomy was associated with lower other-cause mortality (hazard ratio 0.22; p = 0.02); in patients aged 60-69 years, partial nephrectomy was associated with lower other-cause mortality (hazard ratio 0.38; p = 0.03); but not in patients aged ≥70 years.
In metastatic renal cell carcinoma, partial nephrectomy is associated with lower other-cause mortality in patients aged <60 years and in patients aged 60-69 years, but not in patients aged ≥70 years. In consequence, consideration of partial nephrectomy might be of great value in younger metastatic renal cell carcinoma patients.
部分肾切除术降低其他原因死亡率的获益是否适用于转移性肾细胞癌的老年患者尚不清楚。
利用监测、流行病学和最终结果数据库,根据年龄(<60 岁、60-69 岁和≥70 岁)对接受部分或根治性肾切除术的转移性肾细胞癌患者进行分层。在进行倾向评分匹配后,采用 Kaplan-Meier 生存分析和多变量 Cox 回归模型。
在 2390 例转移性肾细胞癌患者中,885 例(37%)年龄<60 岁,其中 90 例(10%)接受了部分肾切除术;824 例(34%)年龄为 60-69 岁,其中 61 例(7%)接受了部分肾切除术;681 例(29%)年龄≥70 岁,其中 64 例(9%)接受了部分肾切除术。在进行倾向评分匹配后,在年龄<60 岁的患者中,部分肾切除术与较低的其他原因死亡率相关(风险比 0.22;p=0.02);在年龄为 60-69 岁的患者中,部分肾切除术与较低的其他原因死亡率相关(风险比 0.38;p=0.03);但在年龄≥70 岁的患者中则不然。
在转移性肾细胞癌中,部分肾切除术与年龄<60 岁和 60-69 岁的患者的其他原因死亡率降低相关,但与年龄≥70 岁的患者无关。因此,对于年轻的转移性肾细胞癌患者,考虑部分肾切除术可能具有重要价值。